Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum
Identifieur interne : 000662 ( PascalFrancis/Checkpoint ); précédent : 000661; suivant : 000663Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum
Auteurs : S. Chen [République populaire de Chine] ; D. Lu [République populaire de Chine] ; M. Zhang [République populaire de Chine] ; J. Che [République populaire de Chine] ; Z. Yin [République populaire de Chine] ; S. Zhang [République populaire de Chine] ; W. Zhang [République populaire de Chine] ; X. Bo [République populaire de Chine] ; Y. Ding [République populaire de Chine] ; S. Wang [République populaire de Chine]Source :
- European journal of clinical microbiology & infectious diseases : (Print) [ 0934-9723 ] ; 2005.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:05-0440639Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum</title><author><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0440639</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0440639 INIST</idno><idno type="RBID">Pascal:05-0440639</idno><idno type="wicri:Area/PascalFrancis/Corpus">000599</idno><idno type="wicri:Area/PascalFrancis/Curation">000391</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000662</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000662</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum</title><author><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></inist:fA14><country>République populaire de Chine</country><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author></analytic><series><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title><title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title><idno type="ISSN">0934-9723</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">European journal of clinical microbiology & infectious diseases : (Print)</title><title level="j" type="abbreviated">Eur. j. clin. microbiol. infect. dis. : (Print)</title><idno type="ISSN">0934-9723</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody</term><term>Antigen</term><term>Coronavirus</term><term>Human</term><term>Serum</term><term>Severe acute respiratory syndrome</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term><term>Antigène</term><term>Anticorps</term><term>Sérum</term><term>Coronavirus</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0934-9723</s0></fA01><fA03 i2="1"><s0>Eur. j. clin. microbiol. infect. dis. : (Print)</s0></fA03><fA05><s2>24</s2></fA05><fA06><s2>8</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum</s1></fA08><fA11 i1="01" i2="1"><s1>CHEN (S.)</s1></fA11><fA11 i1="02" i2="1"><s1>LU (D.)</s1></fA11><fA11 i1="03" i2="1"><s1>ZHANG (M.)</s1></fA11><fA11 i1="04" i2="1"><s1>CHE (J.)</s1></fA11><fA11 i1="05" i2="1"><s1>YIN (Z.)</s1></fA11><fA11 i1="06" i2="1"><s1>ZHANG (S.)</s1></fA11><fA11 i1="07" i2="1"><s1>ZHANG (W.)</s1></fA11><fA11 i1="08" i2="1"><s1>BO (X.)</s1></fA11><fA11 i1="09" i2="1"><s1>DING (Y.)</s1></fA11><fA11 i1="10" i2="1"><s1>WANG (S.)</s1></fA11><fA14 i1="01"><s1>Beijing Institute of Radiation Medicine, 27 Taiping Road</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>6 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ><sZ>9 aut.</sZ><sZ>10 aut.</sZ></fA14><fA14 i1="02"><s1>Glodenweikai Medical Biotechnology Co, Ltd</s1><s2>Beijing 100850</s2><s3>CHN</s3><sZ>4 aut.</sZ><sZ>5 aut.</sZ></fA14><fA20><s1>549-553</s1></fA20><fA21><s1>2005</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>19903</s2><s5>354000132696680080</s5></fA43><fA44><s0>0000</s0><s1>© 2005 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>15 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>05-0440639</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>European journal of clinical microbiology & infectious diseases : (Print)</s0></fA64><fA66 i1="01"><s0>DEU</s0></fA66><fC01 i1="01" l="ENG"><s0>The study presented here was conducted to evaluate the performance of a double-antigen sandwich ELISA to detect antibodies in human serum against the coronavirus associated with severe acute respiratory syndrome (SARS). A recombinant partial nucleocapsid protein of SARS-associated coronavirus was used as a serodiagnostic antigen in the ELISA. A total of 2892 clinical serum samples were tested with the ELISA kit, which positively identified 25 of 35 (71.4%) samples of patients with confirmed SARS infection, 286 of 407 (70%) samples of patients suspected of having SARS, 229 of 302 (75.8%) samples of convalescent SARS patients, and 0 of 544 samples obtained from healthcare workers; only 1 of 1604 clinical samples obtained from patients with other diseases demonstrated a weakly positive result. These results indicate that the double-antigen sandwich ELISA is an effective screening method for the serodiagnosis of SARS-associated coronavirus.</s0></fC01><fC02 i1="01" i2="X"><s0>002B05C02C</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Syndrome respiratoire aigu sévère</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Severe acute respiratory syndrome</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Síndrome respiratorio agudo severo</s0><s2>NM</s2><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Antigène</s0><s5>07</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Antigen</s0><s5>07</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Antígeno</s0><s5>07</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Anticorps</s0><s5>08</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Antibody</s0><s5>08</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Anticuerpo</s0><s5>08</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Sérum</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Serum</s0><s5>09</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Suero</s0><s5>09</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Coronavirus</s0><s2>NW</s2><s5>10</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Coronavirus</s0><s2>NW</s2><s5>10</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Coronavirus</s0><s2>NW</s2><s5>10</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0><s5>11</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Human</s0><s5>11</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0><s5>11</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Coronaviridae</s0><s2>NW</s2></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Coronaviridae</s0><s2>NW</s2></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Coronaviridae</s0><s2>NW</s2></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Nidovirales</s0><s2>NW</s2></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Nidovirales</s0><s2>NW</s2></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Nidovirales</s0><s2>NW</s2></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Virus</s0><s2>NW</s2></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Virus</s0><s2>NW</s2></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Virus</s0><s2>NW</s2></fC07><fC07 i1="06" i2="X" l="FRE"><s0>Appareil respiratoire pathologie</s0><s5>38</s5></fC07><fC07 i1="06" i2="X" l="ENG"><s0>Respiratory disease</s0><s5>38</s5></fC07><fC07 i1="06" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0><s5>38</s5></fC07><fC07 i1="07" i2="X" l="FRE"><s0>Poumon pathologie</s0><s5>39</s5></fC07><fC07 i1="07" i2="X" l="ENG"><s0>Lung disease</s0><s5>39</s5></fC07><fC07 i1="07" i2="X" l="SPA"><s0>Pulmón patología</s0><s5>39</s5></fC07><fN21><s1>305</s1></fN21><fN44 i1="01"><s1>OTO</s1></fN44><fN82><s1>OTO</s1></fN82></pA></standard></inist><affiliations><list><country><li>République populaire de Chine</li></country><settlement><li>Pékin</li></settlement></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Chen, S" sort="Chen, S" uniqKey="Chen S" first="S." last="Chen">S. Chen</name></noRegion><name sortKey="Bo, X" sort="Bo, X" uniqKey="Bo X" first="X." last="Bo">X. Bo</name><name sortKey="Che, J" sort="Che, J" uniqKey="Che J" first="J." last="Che">J. Che</name><name sortKey="Ding, Y" sort="Ding, Y" uniqKey="Ding Y" first="Y." last="Ding">Y. Ding</name><name sortKey="Lu, D" sort="Lu, D" uniqKey="Lu D" first="D." last="Lu">D. Lu</name><name sortKey="Wang, S" sort="Wang, S" uniqKey="Wang S" first="S." last="Wang">S. Wang</name><name sortKey="Yin, Z" sort="Yin, Z" uniqKey="Yin Z" first="Z." last="Yin">Z. Yin</name><name sortKey="Zhang, M" sort="Zhang, M" uniqKey="Zhang M" first="M." last="Zhang">M. Zhang</name><name sortKey="Zhang, S" sort="Zhang, S" uniqKey="Zhang S" first="S." last="Zhang">S. Zhang</name><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000662 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000662 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:05-0440639
|texte= Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum
}}
| This area was generated with Dilib version V0.6.33. |  |